Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.20%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Market Cap
$165.32M
Gross Margin
63.30%
TTM Avg
63.88%
3Y Avg
62.53%
5Y Avg
60.65%
Market Cap
$168.10M
Gross Margin
99.69%
TTM Avg
100.00%
3Y Avg
-73.48%
5Y Avg
-190.92%
Market Cap
$162.04M
Gross Margin
42.60%
TTM Avg
53.28%
3Y Avg
52.45%
5Y Avg
54.03%
Market Cap
$169.53M
Gross Margin
62.24%
TTM Avg
61.05%
3Y Avg
61.66%
5Y Avg
60.51%
Market Cap
$159.80M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
16.67%
Market Cap
$171.13M
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
100.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nkarta, Inc. (NKTX) | $165.27M | 0.00% | 0.00% | 0.00% | 0.00% |
| OptimizeRx Corp. (OPRX)vs › | $165.32M | 63.30% | 63.88% | 62.53% | 60.65% |
| Cue Biopharma, Inc. (CUE)vs › | $168.10M | 99.69% | 100.00% | -73.48% | -190.92% |
| Quanterix Corporation (QTRX)vs › | $162.04M | 42.60% | 53.28% | 52.45% | 54.03% |
| MediWound Ltd. (MDWD)vs › | $168.92M | 15.46% | 16.11% | 25.27% | 28.77% |
| Journey Medical Corporation (DERM)vs › | $169.53M | 62.24% | 61.05% | 61.66% | 60.51% |
| Minerva Neurosciences, Inc. (NERV)vs › | $159.80M | 0.00% | 0.00% | 0.00% | 16.67% |
| PepGen Inc. (PEPG)vs › | $159.78M | 0.00% | 0.00% | 0.00% | 0.00% |
| Precision BioSciences, Inc. (DTIL)vs › | $171.13M | 100.00% | 100.00% | 100.00% | 100.00% |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | 85.91% | 84.21% | 85.09% | 82.87% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | -1735484.42% |
| 2019-09-30 | 1200100.00% |
| 2019-06-30 | -156782.93% |
| 2019-03-31 | -1928.81% |
